| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |